The $120M Editas Medicine Round (August 2015)
Boris Nikolic led Editas Medicine's $120 million CRISPR funding round with Gates co-investing. He briefed Epstein in real time on deal flow and market conditions.
Boris leads $120M CRISPR round
Bloomberg article forwarded to Epstein. Boris: "Have two other similar deals in cooking for Fall." Epstein: "im soooo glad for you"
